Your browser doesn't support javascript.
loading
Bortezomib Relieves Immune Tolerance in Nasopharyngeal Carcinoma via STAT1 Suppression and Indoleamine 2,3-Dioxygenase Downregulation.
Jiang, Guan-Min; Wang, Hong-Sheng; Du, Jun; Ma, Wei-Feng; Wang, Hui; Qiu, Yu; Zhang, Qiu-Gui; Xu, Wei; Liu, Hui-Fang; Liang, Jian-Ping.
Afiliação
  • Jiang GM; Department of Clinical Laboratory, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China. jiangguanmin@hnszlyy.com whongsh@mail.sysu.edu.cn liangjianping@hnszlyy.com.
  • Wang HS; Department of Microbial and Biochemical Pharmacy, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, Guangdong, China. jiangguanmin@hnszlyy.com whongsh@mail.sysu.edu.cn liangjianping@hnszlyy.com.
  • Du J; Department of Microbial and Biochemical Pharmacy, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou, Guangdong, China.
  • Ma WF; Department of Microbiology, School of Public Health and Tropical Medicine, Southern Medical University, Guangzhou, Guangdong, China.
  • Wang H; Key Laboratory of Translational Radiation Oncology, Hunan Province, Changsha, Hunan, China.
  • Qiu Y; Department of ICU, Hunan Children's Hospital, Changsha, Hunan, China.
  • Zhang QG; Department of Clinical Laboratory, The First Affiliated Hospital of University of South China, Hengyang, Hunan, China.
  • Xu W; Department of Clinical Laboratory, The First Affiliated Hospital of University of South China, Hengyang, Hunan, China.
  • Liu HF; Department of Clinical Laboratory, The First Affiliated Hospital of University of South China, Hengyang, Hunan, China.
  • Liang JP; Department of Thoracic Surgery 2, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China. jiangguanmin@hnszlyy.com whongsh@mail.sysu.edu.cn liangjianping@hnszlyy.com.
Cancer Immunol Res ; 5(1): 42-51, 2017 01.
Article em En | MEDLINE | ID: mdl-27923823
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma / Neoplasias Nasofaríngeas / Indolamina-Pirrol 2,3,-Dioxigenase / Fator de Transcrição STAT1 / Bortezomib / Tolerância Imunológica / Antineoplásicos Limite: Humans Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma / Neoplasias Nasofaríngeas / Indolamina-Pirrol 2,3,-Dioxigenase / Fator de Transcrição STAT1 / Bortezomib / Tolerância Imunológica / Antineoplásicos Limite: Humans Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2017 Tipo de documento: Article País de publicação: Estados Unidos